Canaccord Genuity Reiterate Buy Following Workday (WDAY) Q1

Go back to Canaccord Genuity Reiterate Buy Following Workday (WDAY) Q1

Cowen Remains Bullish Following Workday (WDAY) Q1 Results

May 27, 2015 7:04 AM EDT

Cowen maintains an Outperform rating on Workday (NYSE: WDAY), and cuts the price target to $101.00 (from $111.00), following Q1 results. WDAY reported Q1 revenue of $251m, compared to consensus estimates of $245m. Billings were reported at $271.6m vs. $261m consensus. Workday... More

After-Hours Stock Movers 05/26: (EOX) (FPRX) (TIVO) Higher; (VNET) (WDAY) (COT) Lower (more...)

May 26, 2015 6:04 PM EDT

Emerald Oil (NYSE: EOX) 53.6% HIGHER; elected not to proceed with its previously announced public offering of common stock. As a result of the Company's election not to proceed with its public offering, the Company will not be taking action to close the previously announced Delaware Basin acquisition.

Five Prime Therapeutics, Inc. (Nasdaq: FPRX) 20.2% HIGHER; bluebird bio (NASDAQ: BLUE) and Five Prime Therapeutics, Inc. (Nasdaq: FPRX) announced that they... More

Workday, Inc. (WDAY) Tops Q1 EPS by 6c, Offers Q2 Guidance

May 26, 2015 4:05 PM EDT

Workday, Inc. (NYSE: WDAY) reported Q1 EPS of ($0.02), $0.06 better than the analyst estimate of ($0.08). Revenue for the quarter came in at $251 million versus the consensus estimate of $245.01 million.

Workday, Inc. sees Q2 2015 revenue of $270-274 million, versus the consensus of $272.39 million.

For... More